MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway |
Long, Zi-Wen
(Department of Surgery, Shigatse People's Hospital)
Wu, Jiang-Hong (Department of Gastric Cancer Surgery, Fudan University Shanghai Cancer Center) Hong, Cai (Department of Gastric Cancer Surgery, Fudan University Shanghai Cancer Center) Wang, Ya-Nong (Department of Gastric Cancer Surgery, Fudan University Shanghai Cancer Center) Zhou, Ye (Department of Gastric Cancer Surgery, Fudan University Shanghai Cancer Center) |
1 | Chen, L., Wang, J., Wang, B., Yang, J., Gong, Z., Zhao, X., Zhang, C., and Du, K. (2016). MiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling. Ann. Hematol. 95, 365-374. DOI |
2 | Choi, H.J., Lee, H., Kim, H., Kwon, J.E., Kang, H.J., You, K.T., Rhee, H., Noh, S.H., Paik, Y.K., Hyung, W. J., Kim, H. (2010). MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site. Int. J. Cancer 126, 1640-1650. |
3 | Dong, P., Konno, Y., Watari, H., Hosaka, M., Noguchi, M., and Sakuragi, N. (2014). The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer. J. Transl. Med. 12, 231. DOI |
4 | Fresno Vara, J.A., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., and Gonzalez-Baron, M. (2004). PI3K/Akt signalling pathway and cancer. Cancer Treat. Rev. 30, 193-204. DOI |
5 | Fujita, A., Sato, J.R., Rodrigues Lde, O., Ferreira, C.E., and Sogayar, M. C. (2006). Evaluating different methods of microarray data normalization. BMC bioinformatics 7, 469. DOI |
6 | Gao, Q., Ye, F., Xia, X., Xing, H., Lu, Y., Zhou, J., and Ma, D. (2009). Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma. J. Huazhong Univ. Sci. Technolog. Med. Sci. 29, 59-63. DOI |
7 | Lanke, G., and Lee, J.H. (2017). How best to manage gastrointestinal stromal tumor. World J. Clin. Oncol. 8, 135-144. DOI |
8 | Hu, S., Bao, H., Xu, X., Zhou, X., Qin, W., Zeng, C., and Liu, Z. (2015). Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy. FEBS Lett. 589, 4019-4025. DOI |
9 | Isosaka, M., Niinuma, T., Nojima, M., Kai, M., Yamamoto, E., Maruyama, R., Nobuoka, T., Nishida, T., Kanda, T., Taguchi, T., et al. (2015). A screen for epigenetically silenced microRNA genes in gastrointestinal stromal tumors. PloS one 10, e0133754. DOI |
10 | Kanehisa, M., and Goto, S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27-30. DOI |
11 | Li, P., Mao, W.M., Zheng, Z.G., Dong, Z.M., and Ling, Z.Q. (2013). Down-regulation of PTEN expression modulated by dysregulated miR-21 contributes to the progression of esophageal cancer. Dig. Dis. Sci. 58, 3483-3493. DOI |
12 | Liu, G.L., Yang, H.J., Liu, B., and Liu, T. (2017). Effects of microRNA-19b on the proliferation, apoptosis, and migration of Wilms' Tumor cells via the PTEN/PI3K/AKT signaling pathway. J. Cell. Biochem. 118, 3424-3434. DOI |
13 | Sato, T., Shiba-Ishii, A., Kim, Y., Dai, T., Husni, R.E., Hong, J., Kano, J., Sakashita, S., Iijima, T., and Noguchi, M. (2017). miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Cancer Sci. 108, 536-542. DOI |
14 | Lu, X.X., Cao, L.Y., Chen, X., Xiao, J., Zou, Y., and Chen, Q. (2016). PTEN inhibits cell proliferation, promotes cell apoptosis, and induces cell cycle arrest via downregulating the PI3K/AKT/hTERT pathway in lung adenocarcinoma A549 cells. BioMed Res. Int. 2016, 2476842. |
15 | Maehama, T. (2007). PTEN: its deregulation and tumorigenesis. Biol. Pharmaceut. Bull. 30, 1624-1627. DOI |
16 | Markou, A., Zavridou, M., and Lianidou, E.S. (2016). miRNA-21 as a novel therapeutic target in lung cancer. Lung Cancer (Auckl) 7, 19-27. |
17 | Miettinen, M., and Lasota, J. (2001). Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Archiv. 438, 1-12. DOI |
18 | Mogensen, C.E., and Hansen, K.W. (1990). Preventing or postponing renal disease in insulin-dependent diabetes by glycemic and nonglycemic intervention. Contrib. Nephrol. 78, 73-100; discussion 100-101. |
19 | Smyth, G.K. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3. |
20 | Tao, K., Yang, J., Guo, Z., Hu, Y., Sheng, H., Gao, H., and Yu, H. (2014). Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. Am. J. Transl. Res. 6, 391-401. |
21 | Tsang, V.H., Dwight, T., Benn, D.E., Meyer-Rochow, G.Y., Gill, A.J., Sywak, M., Sidhu, S., Veivers, D., Sue, C.M., et al. (2014). Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Endoc. Relat. Cancer 21, 415-426. DOI |
22 | Wu, W. K., Lee C. W., Cho, C.H., Fan, D., Wu, K., Yu, J., and Sung, J.J. (2010). MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29, 5761-5771. DOI |
23 | Tu, K., Liu, Z., Yao, B., Han S., and Yang W. (2016). MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma. Int. J. Oncol. 48, 965-974. DOI |
24 | Valsangkar, N., Sehdev, A., Misra, S., Zimmers, T.A., O'Neil, B.H., and Koniaris, L.G. (2015). Current management of gastrointestinal stromal tumors: Surgery, current biomarkers, mutations, and therapy. Surgery 158, 1149-1164. DOI |
25 | Wang, P., Zou, F., Zhang, X., Li, H., Dulak, A., Tomko, R. J., Jr., Lazo, J.S., Wang, Z., Zhang, L., and Yu, J. (2009). microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 69, 8157-8165. DOI |
26 | Wu, X., Li, S., Xu, X., Wu, S., Chen, R., Jiang, Q., Li, Y., and Xu, Y. (2015). The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. Int J. Clin. Exp. Pathol. 8, 2840-2851. |
27 | Wu, Y.R., Qi, H.J., Deng, D.F., Luo, Y.Y., and Yang, S.L. (2016). MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumour Biol. 37, 12061-12070. DOI |
28 | Xiong, J., Li, Z., Zhang, Y., Li, D., Zhang, G., Luo, X., Jie, Z., Liu, Y., Cao, Y., Le, Z., et al. (2016). PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. Oncol. Rep. 36, 1819-1828. DOI |
29 | Yang, Z., Fang, S., Di, Y., Ying, W., Tan, Y., and Gu, W. (2015). Modulation of NF-kappaB/miR-21/PTEN pathway sensitizes non-small cell lung cancer to cisplatin. PloS one 10, e0121547. DOI |
30 | Ye, M., Li, J., and Gong, J. (2017). PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells. Oncology Rep. 37, 3167-3174. DOI |
31 | Ying, J., Xu, Q., Liu, B., Zhang, G., Chen, L., and Pan, H. (2015). The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis. Onco Targets Ther. 8, 2427-2433. |
32 | Yu, G., Wang, L.G., Han, Y., and He, Q.Y. (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284-287. DOI |
33 | Zhang, Z., Li, Z., Ga,o C., Chen, P., Chen, J., Liu, W., Xiao, S., and Lu, H. (2008). miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab. Invest. 88, 1358-1366. DOI |
34 | Zhu, C.Z., Liu, D., Kang, W.M., Yu, J.C., Ma Z.Q., Ye, X., and Li, K. (2017). Ghrelin and gastrointestinal stromal tumors. World J. Gastroenterol. 23, 1758-1763. DOI |
35 | Cao, C.L., Niu, H.J., Kang, S.P., Cong, C.L., and Kang, S.R. (2016). miRNA-21 sensitizes gastrointestinal stromal tumors (GISTs) cells to Imatinib via targeting B-cell lymphoma 2 (Bcl-2). Eur. Rev. Med. Pharmacol. Sci. 20, 3574-3581. |